JoVE Logo
Faculty Resource Center

Sign In

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

DOI :

10.3791/62488-v

August 12th, 2021

August 12th, 2021

2,777 Views

1Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 3Department of Biotechnology, University of Tehran

The outlined protocol describes the procedure for producing the HiBiT-receptor-binding domain protein complex and its application for fast and sensitive detection of SARS-CoV-2 antibodies.

-- Views

Related Videos

article

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

article

Determining the Phagocytic Activity of Clinical Antibody Samples

article

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes

article

In Vivo Imaging Systems (IVIS) Detection of a Neuro-Invasive Encephalitic Virus

article

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

article

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

article

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

article

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

article

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

article

Indirect Fluorescent Antibody (IFA) Test to Detect Rabies-Specific Antibody Isotypes in Sera or Cerebral Spinal Fluid

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved